SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is seeing a surge in investor sentiment and aggressive short liquidations following news of Treasury bond buybacks and a high-profile industry event focused on favorable regulatory frameworks. The community is actively debating whether this breakout marks the definitive end of the bear market or if it represents a temporary trap before further volatility.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna shares are surging as the company reports positive Phase 3 results for a personalized mRNA melanoma vaccine, sparking intense debate among investors over the clinical significance of the news versus the sustainability of the stock's massive rally. The community is deeply polarized, with bulls cheering the potential breakthrough in oncology, while bears and skeptics are actively questioning the data transparency, high valuation, and the likelihood of a near-term capital raise.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is seeing significant retail interest and upward momentum as investors speculate on a major short squeeze following a record-breaking earnings report. The community is actively debating the stock's potential to reach double digits and beyond, with many comparing it to other fintech peers while closely watching how institutional buying and potential short covering will influence price action.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is experiencing heightened volatility and intense community debate as shareholders weigh the impact of its ongoing share dilution programs against the broader bullish momentum in the Bitcoin market. Investors are actively clashing over whether the stock will leverage Bitcoin's recent price gains or if its complex capital-raising strategy will continue to act as a drag on performance.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is drawing significant attention as investors speculate on a broader bullish turnaround, fueled by a mix of shifting macro liquidity conditions, treasury bond buybacks, and heightened anticipation around potential crypto-friendly regulatory developments. The community remains deeply divided, with bulls pointing to historical technical signals and institutional accumulation to justify their recovery outlook, while bears continue to highlight persistent downside risks and volatility.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BitMine Immersion Technologies is attracting significant attention as investors react to aggressive share buybacks and ongoing efforts to expand its Ethereum treasury holdings amidst broader market anticipation for legislative progress on crypto clarity. The community remains deeply divided, with bulls pointing to the company's improving net asset value and potential for long-term upside while critics express frustration over persistent stock price volatility and management's capital allocation strategies.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is gaining momentum as investors draw positive parallels between its WT1-targeting cancer vaccine pipeline and the successful clinical outcomes recently announced by Moderna and Merck. The community is actively debating the significance of these sector-wide tailwinds, with many longs viewing the current price action as institutional accumulation ahead of highly anticipated, imminent data readouts from the REGAL Phase 3 trial.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck is trending as investors digest positive late-stage clinical data for a personalized mRNA cancer vaccine co-developed with Moderna, signaling significant progress in immunotherapy and oncology. The market is buzzing with speculation about Merck's strategic M&A activity as the company looks to fortify its pipeline ahead of impending patent cliffs for its flagship drug, Keytruda.

Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The firm operates as a digital asset treasury company which focuses on the Hyperliquid ecosystem. The company was founded on July 2, 2025 and is headquartered in New York, NY.

Hyperliquid Strategies Inc.

Hyperliquid Strategies is surging as investors react to potential U.S. market integration and news of high-profile institutional interest, with the community actively tracking record fee generation and the token's significant holdings. Traders are fixated on a potential gamma squeeze driven by rising call volume and upcoming Russell Index inclusion, fueling intense debate over whether the current momentum represents a long-term breakout or a speculative bubble.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors react to a recent earnings beat and guidance raise, with community members closely tracking potential M&A activity and management's ongoing cost-cutting initiatives. The stock is drawing significant attention due to major recent insider buying by executives and directors, fueling discussions about long-term value versus persistent patent-cliff headwinds.

statis crypto Watchlist

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's Why Cognizant (CTSH) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Cognizant and Benchling Selected as Partners to Accelerate Kyowa Kirin's R&D

Cognizant and Benchling Selected as Partners to Accelerate Kyowa Kirin's R&D Cognizant and Benchling Selected as Partners to Accelerate Kyowa Kirin's R&D PR Newswire TOKYO, Aug. 16, 2026 Transforming the Research Lifecycle Through Integrated Data Management, Advanced Automation, and AI-Driven...

The Zacks Analyst Blog Highlights Innodata, ExlService and Cognizant Technology Solutions

Innodata reaffirms at least 40% 2026 revenue growth after a record quarter, with AI opportunities potentially driving further upside.

Innodata Reaffirms 40% Growth Outlook: Is More Upside Ahead?

INOD reaffirms at least 40% 2026 revenue growth, as record Q2 results, customer diversification and untapped pipeline opportunities point to more upside.

Here's Why Cognizant (CTSH) is a Strong Growth Stock

Here's Why Cognizant (CTSH) is a Strong Value Stock

Innodata Before Q2 Earnings: Should You Buy, Sell or Hold the Stock?

INOD's Q2 is expected to witness strong AI demand and operating leverage, supporting growth despite its premium valuation.

Unlocking Cognizant (CTSH) International Revenues: Trends, Surprises, and Prospects

Explore how Cognizant's (CTSH) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

Why Cognizant (CTSH) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Cognizant Q2 Earnings Miss Estimates, Revenues Beat, Rise Y/Y

CTSH's Q2 revenues beat estimates as Financial Services surge, while higher interest costs pressure earnings and 2026 sales guidance was trimmed.


$CTSH Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $1.36 up 3.82% YoY
• Reported revenue of $5.48B up 4.50% YoY
• Cognizant expects full-year 2026 revenue of $22.04 billion to $22.35 billion, while raising its full-year 2026 Adjusted Diluted EPS guidance to a range of $5.70 to $5.82 per share.

Cognizant Technology Solutions Corp. engages in providing information technology, consulting, and business process outsourcing services. Its services include application services, artificial intelligence, business process services, cloud solutions, and core modernization. It operates through the following segments: Healthcare Sciences (HS), Financial Services (FS), Products and Resources (P and R), and Communications, Media, and Technology (CMT). The HS segment is involved in healthcare and life sciences. The FS segment focuses on banking and insurance services. The P and R segment includes retail and consumer goods. The CMT segment relates to communications, information, media and entertainment, and technology. The company was founded by Wijeyaraj Kumar Mahadeva and Francisco D'Souza on April 6, 1988 and is headquartered in Teaneck, NJ.

Cognizant Technology Solutions Corp. - Ordinary Shares - Class A

IBM Stock Suffers Worst Weekly Drop In Six Years – Retail Calls It ‘Generational’ Buying Opportunity While Analysts Remain Cautious

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info